Quantitative EEG
Unlock the potential of advanced analysis techniques to gain deeper insights into brain activity.
BEAM™: A Leader in Innovative Brain Health Approaches
BEAM™ sets personalized brain health care standards by seamlessly integrating EEG with automated neurocognitive tests to compute biomarkers. This advanced biomarker technology, combined with in-depth analytics, not only provides a detailed understanding of neurodegenerative and psychiatric conditions but also assists in differentiating dementia sub-types, quantifying the severity of cognitive decline, tracking disease progression, and assessing treatment efficacy. This comprehensive approach positions BEAM™ at the forefront of brain health innovation, offering precise and personalized medical solutions for the brain.
BEAM™ Biomarkers & Analytics
Neurodegenerative Focus
Targeting Mild Cognitive Impairment, Alzheimer’s, Lewy Body, Parkinson’s, Huntington’s.
Psychiatric Assessment
Addressing Depression, Anxiety, PTSD.
Advanced Technology
Combining EEG with automated neurocognitive tests, referencing an extensive normative database.
Precision Diagnostics
Assisting in differentiating dementia subtypes, quantifying cognitive decline, tracking progression, and assessing treatment efficacy.
Key Features of BEAM™
Proven & Objective
Reliable analytics for precise diagnosis.
Early Detection
Highly sensitive for early-stage identification.
Non-Invasive & Convenient
A straightforward alternative to MRI/PET.
Cost-Effective
Significantly less expensive than conventional imaging.
Regular Monitoring
Ideal for ongoing brain health assessments.
CASE STUDY
Transforming Diagnosis
Subject
64-year-old diagnosed with amnestic MCI.
Findings
Despite normal MMSE scores, BEAM™ biosignature analysis revealed a shift from healthy to MCI, underscoring the sensitivity of our system.
Technology and Compliance
AI-Driven Analysis
Machine learning algorithms for biosignature classification, disease severity quantification, and treatment efficacy assessment
FDA Cleared & HIPAA Compliant
Providing exceptional reliability and stringent data security.
Drug Response Biomarkers
Validated for anxiolytics, antidepressants, and psychedelics.
Empowering Healthcare Providers
Rapid Deployment & Training
Easy-to-use system, quick setup, and 4-hour on-site technician training.
Objective Cognitive Assessment
Thorough evaluation of central and autonomic nervous systems, crucial for accurate clinical decision-making.
The BEAM™ System
21-Channel EEG System: In-depth neurophysiological patient assessments.
Clear, Actionable Reports: Understandable and actionable test results.
Versatile Biomarker Detection: Effective for a wide range of conditions, including dementia, TBI, ADHD, and PTSD.
Revolutionizing Neurocognitive Healthcare with BEAM™
Discover how BEAM™’s integrated system is reshaping the approach to brain health monitoring and care, from healthy aging to managing neurodegenerative decline.
Get Started Now
Neurovative Diagnostics accepts referrals from thousands of hospitals, facilities, physicians, and private practices across the country.